|
Genomic Valley Biotech Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
8.11 Cr.
|
P/BV
|
2.06
|
Book Value (Rs.)
|
12.89
|
|
52 Week High/Low (Rs.)
|
54/20
|
FV/ML
|
10/1
|
P/E(X)
|
268.08
|
|
Bookclosure
|
30/12/2024
|
EPS (Rs.)
|
0.10
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.10 | 1.17 | 0.05 | 2.12 | -0.03 |
| Diluted EPS (Rs.) | 0.10 | 1.17 | 0.05 | 2.12 | -0.03 |
| Cash EPS (Rs.) | 0.11 | 1.17 | 0.05 | 2.15 | 0.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 12.86 | 12.76 | 11.60 | 11.55 | 9.42 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 12.86 | 12.76 | 11.60 | 11.55 | 9.42 |
| Revenue From Operations / Share (Rs.) | 0.87 | 2.76 | 0.54 | 8.91 | 0.23 |
| PBDIT / Share (Rs.) | 0.14 | 1.45 | 0.05 | 3.02 | -0.96 |
| PBIT / Share (Rs.) | 0.13 | 1.45 | 0.04 | 2.99 | -1.24 |
| PBT / Share (Rs.) | 0.13 | 1.45 | 0.04 | 2.12 | -1.38 |
| Net Profit / Share (Rs.) | 0.09 | 1.17 | 0.04 | 2.12 | -0.03 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 16.33 | 52.60 | 9.83 | 33.83 | -416.43 |
| PBIT Margin (%) | 14.95 | 52.30 | 9.17 | 33.54 | -535.97 |
| PBT Margin (%) | 14.95 | 52.30 | 9.17 | 23.83 | -596.37 |
| Net Profit Margin (%) | 11.32 | 42.19 | 9.19 | 23.81 | -13.23 |
| Return on Networth / Equity (%) | 0.77 | 9.13 | 0.42 | 18.38 | -0.32 |
| Return on Capital Employeed (%) | 1.01 | 11.32 | 0.42 | 25.89 | -10.55 |
| Return On Assets (%) | 0.71 | 8.17 | 0.35 | 14.66 | -0.24 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.16 | 0.17 | 0.00 |
| Asset Turnover Ratio (%) | 0.06 | 0.19 | 0.03 | 0.66 | 0.01 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 8.41 | 5.73 | 3.68 | 2.88 | 5.31 |
| Quick Ratio (X) | 7.53 | 5.10 | 3.68 | 2.88 | 5.31 |
| Inventory Turnover Ratio (X) | 0.94 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | -6.89 |
| Interest Coverage Ratio (Post Tax) (%) | 0.00 | 0.00 | 0.00 | 0.00 | -9.05 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 8.53 | 17.85 | 11.20 | 7.21 | 7.56 |
| EV / Net Operating Revenue (X) | 31.87 | 21.15 | 67.84 | 2.65 | 107.10 |
| EV / EBITDA (X) | 195.11 | 40.21 | 689.51 | 7.83 | -25.72 |
| MarketCap / Net Operating Revenue (X) | 31.97 | 21.21 | 64.23 | 2.44 | 107.14 |
| Price / BV (X) | 2.18 | 4.59 | 2.99 | 1.88 | 2.63 |
| Price / Net Operating Revenue (X) | 32.00 | 21.21 | 64.28 | 2.44 | 107.14 |
| EarningsYield | 0.00 | 0.01 | 0.00 | 0.09 | 0.00 |
